Keri Holyoak, PA-C, MPH, Dermatology Center of Salt Lake

Clinical pearls regarding the management of patients with atopic dermatitis with newer treatment approaches as the field continues to evolve.

Strategies that can be used by healthcare professionals to help address patient concerns around atopic dermatitis.

Advice for healthcare professionals who treat atopic dermatitis to help them best manage patients and connect them to other supportive resources.

The importance of partnering with patients who have atopic dermatitis to best support them throughout their long-term journey with the condition.

Considerations regarding how to best select from and use newer therapies for atopic dermatitis.

Current barriers faced by healthcare professionals who treat atopic dermatitis and anticipation regarding opportunities emerging in the field.

Strategies used to evaluate patients and accurately diagnose atopic dermatitis in children and adults.

Patient factors and disease characteristics that impact one’s treatment approach for atopic dermatitis.

Key players in dermatology clinics and steps taken to help patients receive access to newer therapies available to treat atopic dermatitis.

Reactions to the efficacy and safety of dupilumab treatment for atopic dermatitis as demonstrated by clinical trial data and real-world experience.

Keri Holyoak, PA-C, MPH, reacts to the FDA approval of dupilumab for atopic dermatitis and explains what makes this therapy unique compared to other treatment options.

The rationale for using systemic therapies such as methotrexate, azathioprine, phototherapy, or others to treat patients with severe, persistent atopic dermatitis.

Best practices using topical therapies to treat atopic dermatitis and managing treatment-related adverse events.

Non-pharmacological strategies that can help patients with atopic dermatitis cope with symptoms and advice to help healthcare professionals counsel patients on proper use of these products and techniques.

Recommendations on educating primary care physicians about atopic dermatitis and the importance of early referral to dermatologists.

The differences in early skin immune changes in pediatric atopic dermatitis (AD) versus long-standing adult AD and variations in the condition’s presentation among patients of color.

Opening a discussion regarding best practices in managing patients with atopic dermatitis, Douglas DiRuggiero, DMSc, PA-C, describes its relationship to eczema and explains at what age it commonly presents in patients.